Professor Hisham Mehanna is the Chair of Head and Neck Surgery, and Director of the Institute of Head and Neck Studies and Education, at the University of Birmingham, UK.

Hisham’s clinical interests are recurrence head and neck cancer surgery. Prof Mehanna established and ran the UK’s first clinic dedicated to the multi-disciplinary treatment of head and neck and thyroid cancer recurrence.

Hisham has a keen interest in clinical and translational research, heading a research team of 20 researchers, and holding over £17 million in research grants. His main area of his research revolves around improving the management of head and neck cancer through the use of innovative treatments and dynamic risk stratification and assessment. His research spans translational research, early and late phase clinical trials. He is chief investigator of several multicentre and multinational clinical trials, including the PET NECK trial (published in the NEJM in 2016), and the De-escalate study (Lancet 2018) and EPIC HPV (Lancet Onc 2023).

He is also the President of the Head and Neck Cancer International Group (the umbrella organisation of 22 national clinical trials groups), and past President of the British Association of Head Neck Oncologists (BAHNO), and past Chair of the UK’s National Cancer Research Institute’s head and neck group, responsible for all head neck cancer research in the UK.

Otorhinolaryngologist and Surgical Oncologist

Full Professor Otolaryngology/Head and Neck Surgery – Dept. Oncology – University of Turin

Chair Otolaryngology/Head and Neck Unit - San Giovanni Bosco Hospital – Turin

President of European Head and Neck Society

President of Italian University Society of Otolaryngology

Past President of Italian Head and Neck Society

Author of 147 peer reviewed papers and many book chapters mainly focused on laryngeal oncology, partial laryngectomies and, the last ones, on mini-invasive 3D exoscopic surgery.